These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18936238)

  • 1. MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.
    Godet Y; Moreau-Aubry A; Guilloux Y; Vignard V; Khammari A; Dreno B; Jotereau F; Labarriere N
    J Exp Med; 2008 Oct; 205(11):2673-82. PubMed ID: 18936238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy.
    Godet Y; Desfrançois J; Vignard V; Schadendorf D; Khammari A; Dreno B; Jotereau F; Labarrière N
    Eur J Immunol; 2010 Jun; 40(6):1786-94. PubMed ID: 20217862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context.
    Godet Y; Moreau-Aubry A; Mompelat D; Vignard V; Khammari A; Dreno B; Lang F; Jotereau F; Labarriere N
    Cancer Immunol Immunother; 2010 Mar; 59(3):431-9. PubMed ID: 19730858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
    Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
    J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.
    Schiavetti F; Thonnard J; Colau D; Boon T; Coulie PG
    Cancer Res; 2002 Oct; 62(19):5510-6. PubMed ID: 12359761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes.
    Robbins PF; el-Gamil M; Li YF; Topalian SL; Rivoltini L; Sakaguchi K; Appella E; Kawakami Y; Rosenberg SA
    J Immunol; 1995 Jun; 154(11):5944-50. PubMed ID: 7751637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human melanoma-specific peptide antigens recognized by HLA-A2 restricted tumor-infiltrating lymphocytes].
    Ge H; Bao Z
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):658-61. PubMed ID: 9275546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
    Carlsson B; Sadeghi A; Bengtsson M; Wagenius G; Tötterman TH
    J Immunother; 2008 Sep; 31(7):633-43. PubMed ID: 18600181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation of a modified tumor-derived peptide by tumor infiltrating lymphocytes.
    Dionne SO; Smith MH; Marincola FM; Lake DF
    Cell Immunol; 2001 Dec; 214(2):139-44. PubMed ID: 12088412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.
    Shichijo S; Azuma K; Komatsu N; Ito M; Maeda Y; Ishihara Y; Itoh K
    Clin Cancer Res; 2004 Sep; 10(17):5828-36. PubMed ID: 15355913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage.
    Maeurer MJ; Hurd S; Martin DM; Storkus WJ; Lotze MT
    Cancer J Sci Am; 1995; 1(2):162-70. PubMed ID: 9166469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.
    Huang LQ; Brasseur F; Serrano A; De Plaen E; van der Bruggen P; Boon T; Van Pel A
    J Immunol; 1999 Jun; 162(11):6849-54. PubMed ID: 10352307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
    Gaudin C; Kremer F; Angevin E; Scott V; Triebel F
    J Immunol; 1999 Feb; 162(3):1730-8. PubMed ID: 9973436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients.
    González FE; Ramírez M; Allerbring EB; Fasching N; Lundqvist A; Poschke I; Achour A; Salazar-Onfray F
    Immunobiology; 2014 Mar; 219(3):189-97. PubMed ID: 24192537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy.
    Robbins PF; el-Gamil M; Kawakami Y; Stevens E; Yannelli JR; Rosenberg SA
    Cancer Res; 1994 Jun; 54(12):3124-6. PubMed ID: 8205528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames.
    Wang RF; Johnston SL; Zeng G; Topalian SL; Schwartzentruber DJ; Rosenberg SA
    J Immunol; 1998 Oct; 161(7):3598-606. PubMed ID: 9759882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.
    Sensi M; Pietra G; Molla A; Nicolini G; Vegetti C; Bersani I; Millo E; Weiss E; Moretta L; Mingari MC; Anichini A
    Int Immunol; 2009 Mar; 21(3):257-68. PubMed ID: 19181932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte.
    Lethé B; van der Bruggen P; Brasseur F; Boon T
    Melanoma Res; 1997 Aug; 7 Suppl 2():S83-8. PubMed ID: 9578421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patient.
    Nagata Y; Hanagiri T; Takenoyama M; Fukuyama T; Mizukami M; So T; Ichiki Y; Sugaya M; Sugio K; Yasumoto K
    Clin Cancer Res; 2005 Jul; 11(14):5265-72. PubMed ID: 16033845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.